Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03583593

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose supportive care
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Catalysis SL (from the registry)
Registry
  • NCT NCT03583593
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Cuba (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03583593. Randomized; double masking; primary purpose supportive care. Start 2014-05-23 (actual); primary completion 2017-11-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer
Condition
Diabetic Foot Ulcer
Condition
Diabetic Foot
Condition
Diabetes Mellitus, Type 2
Intervention (Dietary supplement)
DIAMEL
Intervention (Dietary supplement)
Placebo
Lead sponsor
Catalysis SL (class: industry)

Record details

Record id
cardio:ct-nct03583593
Content hash
770b99be251909f318c42e895f71acc5282a064fe04fc6803f975ca445e8829f